• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Aviva Investors UK Index Tracking Fund SC 2 Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Aviva Investors UK Fund Services Limited
Fund Summary The Fund aims to track the performance of the FTSE® All-Share Index (before charges and taxes). Any returns will be a combination of capital growth and income. The Fund will invest directly into shares of companies listed on the FTSE® All-Share Index (the ™Index™). The Fund may also invest in other funds (including funds managed by Aviva Investors companies), cash and deposits. Derivatives, such as futures, may be used from time to time to gain a particular market exposure which would otherwise be difficult or costly to achieve, or to manage the Fund™s cash flows in a cost-effective manner, this type of derivative usage is called ™efficient portfolio management™.
SEDOL code B8XCGM2
ISIN GB00B8XCGM21
Fund code NUITI
Managers Ned Kelly
Manager Tenure 3 years
Morningstar Category UK Large-Cap Equity
IMA Sector UK All Companies
Fund Size £722 million
Fund Type OEIC
Management Style Passive
Ongoing Charge Figure (OCF) 0.2%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.1119
Buy Price £1.1119
Price Change +1.3583%
Price Date 2nd July 2020
Yield 4.60%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 13th June 2013
Fund Status OPEN
Ned provides fund management capabilities for our clients in respect of UK and International Index Funds. Prior to joining us, Ned worked for Legal & General Investment Management as an index fund analyst. Before L&G, he was with Barclays Global Investors as a client accountant. Ned holds a BA (Hons) in European Business Systems from London Guildhall University.

3-year Mean Monthly Return: -0.050%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance -12.75% +0.44% +8.70% +17.58% +1.93% +2.42% +12.63% +17.18% -3.99% +24.26%
Benchmark Performance
(UK Large-Cap Equity)
-12.41% -0.54% +7.78% +19.70% -1.91%
Time Period Cumulative Benchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day -1.14% -17.46% +16.32%
1 week 0.25% -1.63% +1.87%
1 month -3.19% +17.03% -20.22%
3 months 15.97% -17.71% +33.68%
6 months -17.81% -14.36% -3.44%
1 year -14.61% -2.11% -12.50%
3 years -1.79% +1.80% -3.59%
5 years 2.52% +6.85% -4.33%
10 years 6.46% +6.73% -0.26%
YTD -17.04% -0.55% -16.49%
Since inception 6.73% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
AstraZeneca PLC GBR 5.87%
GlaxoSmithKline PLC GBR 4.27%
HSBC Holdings PLC GBR 3.90%
British American Tobacco PLC GBR 3.79%
Diageo PLC GBR 3.36%
BP PLC GBR 3.17%
Royal Dutch Shell PLC Class A GBR 2.71%
Rio Tinto PLC GBR 2.47%
Unilever PLC GBR 2.46%
Royal Dutch Shell PLC B GBR 2.39%
Dividend Date Per share amount Reinvestment Price
16th April 2020 0.0176 £0.9939
16th October 2019 0.0302 £1.2668
16th April 2019 0.0230 £1.3101
16th October 2018 0.0280 £1.2432
16th April 2018 0.0205 £1.2724
16th October 2017 0.0254 £1.3244